In contrast, a small but detectable fraction (range 2.7 – 3.2%; mean = 2.9%) of CD9+ exosomes from non-cancer healthy controls had GFAP on their surface (a 7.9-fold difference; Table 2). The gene discussed is CD9; the disease is cancer.